Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class Ii-Restricted Peptides from Melanoma-Associated Antigens

Cancer vaccines targeting CD8(+) T cells have been successful in eliciting immunologic responses but disappointing in inducing clinical responses. Strong evidence supports the importance of CD4(+) T cells in “helping” cytotoxic CD8(+) cells in antitumor immunity. We report here on two consecutive cl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Phan, Giao Q., Touloukian, Christopher E., Yang, James C., Restifo, Nicholas P., Sherry, Richard M., Hwu, Patrick, Topalian, Suzanne L., Schwartzentruber, Douglas J., Seipp, Claudia A., Freezer, Linda J., Morton, Kathleen E., Mavroukakis, Sharon A., White, Donald E., Rosenberg, Steven A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2003
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1679660/
https://ncbi.nlm.nih.gov/pubmed/12843797
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky